Role of sociodemographic, clinical, behavioral, and molecular factors in precision prevention of type 2 diabetes: a systematic review

• Published in: medRxiv : the preprint server for health sciences
• Main Authors: Bodhini, Dhanasekaran, Morton, Robert W, Santhakumar, Vanessa, Nakabuye, Mariam, Pomares-Millan, Hugo, Clemmensen, Christoffer, Fitzpatrick, Stephanie L, Guasch-Ferre, Marta, Pankow, James S, Ried-Larsen, Mathias, Franks, Paul W, Tobias, Deirdre K, Merino, Jordi, Mohan, Viswanathan, Loos, Ruth J F
• Format: Journal Article
• Language: English
• Published: United States 03.05.2023

The variability in the effectiveness of type 2 diabetes (T2D) preventive interventions highlights the potential to identify the factors that determine treatment responses and those that would benefit the most from a given intervention. We conducted a systematic review to synthesize the evidence to support whether sociodemographic, clinical, behavioral, and molecular characteristics modify the efficacy of dietary or lifestyle interventions to prevent T2D. Among the 80 publications that met our criteria for inclusion, the evidence was low to very low to attribute variability in intervention effectiveness to individual characteristics such as age, sex, BMI, race/ethnicity, socioeconomic status, baseline behavioral factors, or genetic predisposition. We found evidence, albeit low certainty, to support conclusions that those with poorer health status, particularly those with prediabetes at baseline, tend to benefit more from T2D prevention strategies compared to healthier counterparts. Our synthesis highlights the need for purposefully designed clinical trials to inform whether individual factors influence the success of T2D prevention strategies.